Literature DB >> 215272

Pre- and postsynaptic neurochemical alterations in Alzheimer's disease.

T D Reisine, H I Yamamura, E D Bird, E Spokes, S J Enna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215272     DOI: 10.1016/0006-8993(78)90562-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  25 in total

1.  Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood.

Authors:  V Hinz; S Grewig; B H Schmidt
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

2.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.

Authors:  E D London; M J Ball; S B Waller
Journal:  Neurochem Res       Date:  1989-08       Impact factor: 3.996

4.  Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.

Authors:  K J Reinikainen; P J Riekkinen; L Paljärvi; H Soininen; E L Helkala; J Jolkkonen; M Laakso
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

5.  Specific disruption of spatial behaviour in rats by central muscarinic receptor blockade.

Authors:  P Willner; D Wise; T Ellis
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 6.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

7.  Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group.

Authors:  F P Zemlan
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multi-infarct dementia.

Authors:  E Perdahl; R Adolfsson; I Alafuzoff; K A Albert; E J Nestler; P Greengard; B Winblad
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

9.  The noradrenergic system in Alzheimer and multi-infarct dementias.

Authors:  D M Mann; P O Yates; J Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

10.  Confusion, dementia and anticholinergics in Parkinson's disease.

Authors:  Y de Smet; M Ruberg; M Serdaru; B Dubois; F Lhermitte; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.